원저 : 102명의 비흑색종 피부암 환자에 대한 Mohs 미세도식수술 치료 경험
분야
의약학 > 피부과학
저자
양보희 ( Bo Hee Yang ) , 변지원 ( Ji Won Byun ) , 이승규 ( Seung Gyu Lee ) , 인승균 ( Seung Gyun In ) , 이현숙 ( Hyeon Sook Lee ) , 정기양 ( Kee Yang Chung ) , 신정현 ( Jeong Hyun Shin ) , 최광성 ( Gwang Seong Choi ) , 송희진 ( Hee Jin Song )
발행기관
대한피부과학회
간행물정보
대한피부과학회지 2012년, 제50권 제11호, 931~936페이지(총6페이지)
파일형식
27728506.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    4,500원
    적립금
    135원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    영문초록
    Background: Mohs micrographic surgery (MMS) is a specialized type of minimal marginal surgery, which offers superior cure rates to other options in the treatment of non-melanoma skin cancers. Objective: The aim of this study is to investigate the clinical characteristics and recurrence rate of the non-melanoma skin cancer and to estimate the safeties of MMS. Methods: We retrospectively evaluated 102 patients who had been diagnosed with non-melanoma skin cancer and treated by MMS from May 2008 to September 2011. Results: The most common cancer was basal cell carcinoma (63.72%), followed by squamous cell carcinoma (31.38%). The local flap was the most common method to repair surgical defects (74.5%), followed by primary closure (17.64%). Cervical lymph node metastasis was confirmed in 1 case (0.98%). Recurrence after MMS was observed in 1 of 102 patients (0.98%). Conclusion: MMS is a safe method for the treatment of non-melanoma skin cancer. (Korean J Dermatol 2012;50(11):931∼936)
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
    copyright (c) 2009 happynlife. steel All reserved.